Finanzen von Joint Corp (JYNT)JYNTJoint Corp

Joint Corp (JYNT) generates its revenue primarily from Franchise Operations, which accounts for 100.0% of total sales, equivalent to $13.08M. Understanding this concentration is critical for investors evaluating how JYNT navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Joint Corp maintains a gross margin of 80.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1.06%, while the net margin is -1.66%. These profitability ratios, combined with a Return on Equity (ROE) of 10.64%, provide a clear picture of how effectively JYNT converts its operational activities into shareholder value.

In the context of the broader market, JYNT competes directly with industry leaders such as BNR and NAKA. With a market capitalization of $119.37M, it holds a significant position in the sector. When comparing efficiency, JYNT's gross margin of 80.90% stands against BNR's 72.27% and NAKA's 49.70%. Such benchmarking helps identify whether Joint Corp is trading at a premium or discount relative to its financial performance.

Joint Corp has shown a gross margin improvement, reaching 80.90% in Q2 2026, up from 75.02% in Q3 2024. However, the company has faced challenges with net income, reporting a loss in several quarters, including a net income of 653021 in Q2 2026, which is a decline from previous quarters.